As of 2025-05-17, the Relative Valuation of China SXT Pharmaceuticals Inc (SXTC) is 5.14 USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.20 USD, the upside of China SXT Pharmaceuticals Inc based on Relative Valuation is 328.5%.
The range of the Relative Valuation is 3.93 - 6.67 USD.
| Range | Selected | |
| Trailing P/E multiples | 19.6x - 25.0x | 21.1x |
| Forward P/E multiples | 14.8x - 21.2x | 17.5x |
| Fair Price | 3.93 - 6.67 | 5.14 |
| Upside | 227.7% - 455.5% | 328.5% |
| Date | P/E |